Skip to content
Premier Weight Loss Indianapolis
GLP-1 Medications

Medical Weight Loss in Indianapolis

Brand-name GLP-1 medications — Mounjaro®, Zepbound®, Wegovy®, and Ozempic® — prescribed directly from our Indianapolis clinics at up to 75% less than retail pharmacies. Physician-supervised care with body composition tracking.

Call (317) 567-9100
  • 500+

    Patients Treated

  • 4.9

    Patient Rating

  • Board-Certified

    Medical Director

  • In-Person & Telehealth

    Statewide Indiana

Compare Side-by-Side

Choose Your Medication

Our medical team will recommend the best option based on your goals, health profile, and treatment response.

  • Tirzepatide

    Mounjaro®

    Dual-action weight loss with blood sugar control.

    • Avg loss

      20–22%

    • Frequency

      Weekly

    $275/mo

    vs $1100 retail

    Learn more →
  • Tirzepatide

    Zepbound®

    Most Effective

    FDA-approved specifically for chronic weight management.

    • Avg loss

      20–22%

    • Frequency

      Weekly

    $275/mo

    vs $1050 retail

    Learn more →
  • Semaglutide

    Wegovy®

    The proven GLP-1 for weight loss with cardiovascular benefits.

    • Avg loss

      15–17%

    • Frequency

      Weekly

    $175/mo

    vs $1350 retail

    Learn more →
  • Semaglutide

    Ozempic®

    Most Popular

    The original semaglutide. Off-label for weight loss with proven results.

    • Avg loss

      14–15%

    • Frequency

      Weekly

    $175/mo

    vs $1000 retail

    Learn more →
How They Work

How GLP-1 Medications Work

GLP-1 receptor agonists mimic a natural hormone your body produces, working with your biology not against it.

  • Reduces Hunger Signals

    GLP-1s act on the appetite centers of your brain, reducing food noise and helping you feel full faster, longer.

  • Slows Digestion

    Slower gastric emptying means food stays in your stomach longer, sustaining fullness and stabilizing energy between meals.

  • Regulates Blood Sugar

    GLP-1s improve insulin response and reduce glucagon, helping blood sugar stay steady and supporting fat metabolism.

Compare

Compare All Options

All four are FDA-approved, brand-name, prescribed in clinic, and never compounded.

MedicationGenericMechanismFDA IndicationAvg Weight LossDosing
Mounjaro®TirzepatideDual GIP / GLP-1 receptor agonistType 2 Diabetes20–22%Weekly subcut. injection
Zepbound®TirzepatideDual GIP / GLP-1 receptor agonistChronic weight management20–22%Weekly subcut. injection
Wegovy®SemaglutideGLP-1 receptor agonistChronic weight management15–17%Weekly subcut. injection
Ozempic®SemaglutideGLP-1 receptor agonistType 2 Diabetes15–17%Weekly subcut. injection

Medically reviewed by Dr. Scott Friedman, MD ·

FAQ

Common Questions

  • Which GLP-1 medication is most effective?

    Tirzepatide (Mounjaro/Zepbound) has shown the highest weight loss in clinical trials at 20 to 22% body weight, while semaglutide (Wegovy/Ozempic) typically delivers 14 to 17%. Your medical team will recommend the best option based on your goals and health profile.

  • Are these medications brand-name or compounded?

    Premier Weight Loss prescribes only brand-name, FDA-approved GLP-1 medications. We never use compounded alternatives. All medications come in their original manufacturer packaging.

  • How are you cheaper than retail pharmacies?

    Most retail pharmacies focus on insurance billing rather than the best cash-pay price. Premier utilizes options like NovoCare, LillyDirect, and physician-directed off-label dosing to make brand-name medication treatment more affordable.

  • Do I need to choose a medication before my appointment?

    No. Your medical team will recommend the best medication and starting dose for you during your initial visit, based on your goals, medical history, and any contraindications.

  • What are the most common side effects?

    Nausea, mild GI changes, constipation, and occasional acid reflux are most common, especially in the first few weeks. Most resolve with dose adjustment, hydration, increased fiber and protein, and time. Severe side effects are rare and your provider monitors closely throughout treatment.

  • Can I get GLP-1 medication delivered via telehealth?

    Yes. Zepbound, Wegovy, and Ozempic can all be prescribed via virtual visit and shipped to your door. Mounjaro requires an initial in-clinic visit. Virtual patients also receive a free $379 InBody H30 body composition scale.

Projected Results

What 15–22% Weight Loss Looks Like

Based on a 250 lb starting weight. Individual results vary based on starting weight, adherence, and lifestyle factors.

  • Semaglutide

    Wegovy · Ozempic

    37–42 lbs

    15–17% body weight loss

  • Tirzepatide

    Mounjaro · Zepbound

    50–55 lbs

    20–22% body weight loss

Aesthetic Services

Pair Weight Loss with Aesthetic Care

Members save up to 35% on every aesthetic treatment.

  • Featured

    RF Microneedling

    Morpheus8®

    Radiofrequency microneedling for skin tightening, texture refinement, and collagen stimulation. Pair with GLP-1 to address loose skin during rapid weight loss.

    Learn about Morpheus8 →
  • Popular

    Injectables

    Botox®

    Smooth fine lines and wrinkles with precision injections. Member rate $11–12/unit. Performed only by licensed medical professionals under physician supervision.

    Learn about Botox →
Service Area

Serving All of Central Indiana

In-clinic care at two Indianapolis-area locations, plus virtual care statewide for any Indiana resident.

  • Indianapolis
  • Carmel
  • Fishers
  • Noblesville
  • Westfield
  • Zionsville
  • Greenwood
  • Avon
  • Brownsburg
  • Lawrence
  • Anderson
  • Bloomington
  • Columbus
  • Muncie
  • Plainfield
  • Speedway
  • Beech Grove
  • McCordsville
  • Geist
  • Cumberland
  • Whitestown
  • Lebanon
  • Pendleton
  • Greenfield
  • Mooresville
  • Danville
  • Bargersville
  • Franklin

Ready to Start Your Weight Loss Journey?

Final medication recommendations are made individually during your consultation. $45 secures your spot and applies in full to your first visit.